山东大学学报 (医学版) ›› 2020, Vol. 58 ›› Issue (4): 84-89.doi: 10.6040/j.issn.1671-7554.0.2019.1388
徐红照1,郝宗山2, 沈德嫱3,李朝苹4,陈立勇4
XU Hongzhao1, HAO Zongshan2, SHEN Deqiang3, LI Zhaoping4, CHEN Liyong4
摘要: 目的 探讨核糖体蛋白S6激酶2(S6K2)沉默在乙醇诱导的心肌胰岛素抵抗中的作用。 方法 采用荧光标记2-脱氧葡萄糖(2-NDBG)摄取实验及葡萄糖氧化酶法检测在100 mmol乙醇刺激下,沉默S6K2前后心肌细胞H9c2糖摄取能力。采用Western blotting法检测乙醇处理及病毒转染前后S6K2蛋白表达量及胰岛素受体底物 1(p-IRS-1)磷酸化情况。采用q-PCR及Western blotting法检测慢病毒转染后S6K2的沉默情况。 结果 乙醇刺激降低了心肌细胞H9c2葡萄糖摄取,2-NDBG平均荧光强度降低46.5%(P=0.016),同时p-IRS-1(Ser)蛋白表达量提高14.4%(P=0.024),S6K2在mRNA及蛋白水平表达分别上调16.8%和23.5%(P=0.009,P=0.029)。S6K2沉默后,乙醇刺激对H9c2心肌细胞糖摄取及p-IRS-1(Ser)的表达差异无统计学意义(P=0.665,P=0.740)。 结论 乙醇刺激导致心肌细胞糖摄取障碍,诱导胰岛素抵抗,S6K2沉默能够有效改善乙醇诱导的心肌细胞葡萄糖摄取障碍及胰岛素抵抗现象。
中图分类号:
| [1] Mogos MF, Salemi JL, Phillips SA, et al. Contemporary appraisal of sex differences in prevalence, correlates, and outcomes of alcoholic cardiomyopathy [J]. Alcohol Alcohol, 2019, 54(4): 386-395. [2] 张天懿, 高卫民, 曹志鹏, 等. 酒精性心肌病的研究进展及其法医学鉴定[J]. 法医学杂志, 2019, 35(6): 721-725. ZHANG Tianyi, GAO Weimin, CAO Zhipeng, et al. Research progress and forensic identification of alcoholic cardiomyopathy [J]. Journal of Forensic Medicine, 2019, 35(6): 721-725. [3] Li SY, Ren J. Cardiac overexpression of alcohol dehydrogenase exacerbates chronic ethanol ingestion-induced myocardial dysfunction and hypertrophy: role of insulin signaling and ER stress [J]. J Mol Cell Cardiol, 2008, 44(6): 992-1001. [4] Dinh W, Lankisch M, Nickl W, et al. Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study [J]. Cardiovasc Diabetol, 2010, 9: 63. doi:10.1186/1475-2840-9-63. [5] Novo G, Pugliesi M, Visconti C, et al. Early subclinical ventricular dysfunction in patients with insulin resistance [J]. J Cardiovasc Med(Hagerstown), 2014, 15(2): 110-114. [6] Lee-Fruman KK, Kuo CJ, Lippincott J, et al. Characterization of S6K2, a novel kinase homologous to S6K1 [J]. Oncogene, 1999, 18(36): 5108-5114. [7] Fernández-Solà J. Cardiovascular risks and benefits of moderate and heavy alcohol consumption [J]. Nat Rev Cardiol, 2015, 12(10): 576-587. [8] Day E, Rudd JHF. Alcohol use disorders and the heart [J]. Addiction, 2019, 114(9): 1670-1678. [9] Fu F, Zhao K, Li J, et al. Direct evidence that myocardial insulin resistance following myocardial ischemia contributes to post-ischemic heart failure [J]. Sci Rep, 2016, 5: 17927. doi:10.1038/srep17927. [10] Yazıcı D, Sezer H. Insulin resistance, obesity and lipotoxicity [J]. Adv Exp Med Biol, 2017, 960: 277-304. doi:10.1007/978-3-319-48382-5_12. [11] Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase(S6K)within mTOR signalling networks [J]. Biochem J, 2012, 441(1): 1-21. [12] Goh ET, Pardo OE, Michael N, et al. Involvement of heterogeneous ribonucleoprotein F in the regulation of cell proliferation via the mammalian target of rapamycin/S6 kinase 2 pathway [J]. J Biol Chem, 2010, 285(22): 17065-17076. [13] Foster KG, Fingar DC. Mammalian target of rapamycin(mTOR): conducting the cellular signaling symphony [J]. J Biol Chem, 2010, 285(19): 14071-14077. [14] Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing [J]. Nat Rev Mol Cell Biol, 2011, 12(1): 21-35. [15] 魏荣芳, 郭梦婕, 钱进军, 等. p70S6K1在结直肠癌中的作用及潜在分子机制(英文)[J]. 南京中医药大学学报, 2019, 35(5): 613-622. [16] 王新, 于跃利. mTOR及其下游分子4EBP1和S6K1与结直肠腺癌关系的研究[J]. 系统医学, 2019, 4(3): 193-195. [17] Filonenko VV, Tytarenko R, Azatjan SK, et al. Immunohistochemical analysis of S6K1 and S6K2 localization in human breast tumors [J]. Exp Oncol, 2004, 26(4): 294-299. [18] 韩冰, 赵国军, 兰素伟, 等. 宫颈癌组织中S6K1和S6K2的表达及其临床意义[J]. 中国老年学杂志, 2017, 37(9): 2182-2185. [19] Blouet C, Ono H, Schwartz GJ. Mediobasal hypothalamic p70S6 kinase 1 modulates the control of energy homeostasis [J]. Cell Metab, 2008, 8(6): 459-467. [20] Pende M, Kozma SC, Jaquet M, et al. Hypoinsulinaemia, glucose intolerance and diminished-cell size in S6K1-deficient mice [J]. Nat, 2000, 408(6815): 994-997. [21] Karlsson E, Magic I, Bostner J, et al. Revealing different roles of the mTOR-targets S6K1 and S6K2 in breast cancer by expression profiling and structural analysis [J]. PLoS ONE, 2015, 10(12): e0145013. doi: 10.1371/journal.pone.0145013. [22] Lyzogubov V, Khozhaenko Y, Usenko V, et al. Immunohistochemical analysis of Ki-67, PCNA and S6K1/2 expression in human breast cancer [J]. Exp Oncol, 2005, 27(2): 141-144. [23] Pardo OE, Seckl MJ. S6K2: The neglected S6 kinase family member [J]. Front in Oncol, 2013, 3: 191. doi: 10.3389/fonc.2013.00191. [24] Sun Y, Luo M, Chang G, et al. Phosphorylation of Ser6 in hnRNPA1 by S6K2 regulates glucose metabolism and cell growth in colorectal cancer [J]. Oncol Lett, 2017, 14(6): 7323-7331. [25] Sever N(·overI), Cengiz ?瘙塁ahin S. S6K2 promises an important therapeutic potential for cancer [J]. Future Oncol, 2019, 15(1): 95-102. [26] Ismail HM, Myronova O, Tsuchiya Y, et al. Identification of the general transcription factor Yin Yang 1 as a novel and specific binding partner for S6 Kinase 2 [J]. Cell Signal, 2013, 25(5): 1054-1063. [27] Miller WP, Ravi S, Martin TD, et al. Activation of the stress response kinase JNK(c-Jun N-terminal Kinase)attenuates insulin action in retina through a p70S6K1-dependent mechanism [J]. J Biol Chem, 2017, 292(5): 1591-1602. [28] Chen J, Sun J, Prinz RA. Gingerenone A sensitizes the insulin receptor and increases glucose uptake by inhibiting the activity of p70 S6 kinase [J]. Mol Nutr Food Res, 2018, 62(23): e1800709. doi: 10.1002/mnfr.201800709. [29] Cao Y, Sun W, Xu G. Fuzhu jiangtang granules combined with metformin reduces insulin resistance in skeletal muscle of diabetic rats via PI3K/Akt signaling [J]. Pharm Biol, 2019, 57(1): 660-668. |
| [1] | 徐宁宇 王磊 郝恩魁 苏国海. STEMI患者急诊PCI前口服阿托伐他汀对炎症介质及左心室功能的影响[J]. 山东大学学报(医学版), 2209, 47(6): 69-72. |
| [2] | 张媛 李英敏 冯月秋 常彩云 潘华伟 王束玫. 血清脂联素水平与肥胖、胰岛素抵抗的关系探讨[J]. 山东大学学报(医学版), 2209, 47(6): 124-. |
| [3] | 申路佳,逯天威,巩伟明,赵岩松,王淑康,袁中尚. 代谢风险评分在2型糖尿病人群心血管结局预测中的应用[J]. 山东大学学报 (医学版), 2025, 63(8): 69-78. |
| [4] | 河南省生物医学工程学会立体心电图专业委员会,中国医药教育协会心电学专业委员会,山东中医药学会心电学专业委员会,青岛市医学会心电生理与起搏专科分会,全国医药技术市场协会远程心脏专业委员会. 心电向量图诊断标准规范化专家共识(2025)[J]. 山东大学学报 (医学版), 2025, 63(7): 1-10. |
| [5] | 赵志敏,王春,李白翎. del Nido停搏液在心脏外科的应用:过去、现在与未来[J]. 山东大学学报 (医学版), 2025, 63(5): 54-59. |
| [6] | 温学龙,刘安慧,陈经纬,吴梦婷,杨岷. 急性非ST抬高型心肌梗死行冠状动脉旁路移植手术时机Meta分析[J]. 山东大学学报 (医学版), 2025, 63(5): 60-70. |
| [7] | 孟妍,张晨一,刘峰,陈立勇. 功能食品对酒精性心肌病防护作用的研究进展[J]. 山东大学学报 (医学版), 2024, 62(8): 27-33. |
| [8] | 刘淋,王晓楠,杨雅溪,王江腾,李旭,周新丽,管庆波,张栩. 甘油三酯-葡萄糖指数与颅内动脉粥样硬化性狭窄的相关性[J]. 山东大学学报 (医学版), 2024, 62(8): 93-100. |
| [9] | 许沛晨,李晓博,庄向华,娄能俊,吕丽,周玲雁,牟亚朋,宋玉文,陈诗鸿. 儿童Alstrom综合征2例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(3): 107-111. |
| [10] | 王震,颜凤,宗孟至,徐峰,陈玉国,李传保. Turner综合征并发急性心肌梗死1例[J]. 山东大学学报 (医学版), 2024, 62(2): 109-112. |
| [11] | 杨晓斐,韩波,姜殿东,吕建利,伊迎春,张建军,赵立健,王静,王艳,袁辉. 经导管射频消融术治疗儿童快速性心律失常972例临床分析[J]. 山东大学学报 (医学版), 2023, 61(2): 49-56. |
| [12] | 聂佩,王锡明. 人工智能在心肌影像应用中的研究进展[J]. 山东大学学报 (医学版), 2023, 61(12): 1-6. |
| [13] | 林杨,颜豪森,陈琦,陈裕玺,王玖. 急性心肌梗死智能辅助诊断模型构建及应用[J]. 山东大学学报 (医学版), 2023, 61(1): 86-93. |
| [14] | 姜卉,魏甜,李建平,王聪. 葛根素对索拉非尼心肌毒性的保护及作用机制[J]. 山东大学学报 (医学版), 2022, 60(8): 14-22. |
| [15] | 张玉凤,徐敏,邢秀丽,逄曙光,户克庆. 689例非ST段抬高型心肌梗死患者的临床流行病学特征[J]. 山东大学学报 (医学版), 2022, 60(7): 118-122. |
|
||